Bixiye
Ophthalmic Antihistamine - Commercial
Step Therapy
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 01, 2024
Natiijooyinka Raadinta
Soo bandhiga 2061 - 2070 ee natiijooyinka 3690
Bixiye
Non-Preferred Drug with Continuation of Therapy - Medicaid
Oggolaanshaha Hore
Taariikhda wax ku ool ah ee barnaamijka: Jun 01, 2025
Bixiye
Lupus - Commercial
Prior Authorization, Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: Des 01, 2024
Bixiye
Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) - Commercial
Prior Authorization, Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 01, 2025
Bixiye
Constipation Agents - Medicaid
Prior Authorization, Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: Jan 01, 2025
Bixiye
P59-21 New: eviCore Home Health Care (HHC) Supplementary Guidelines for Medicare Advantage Subscribers
Taariikhda uu dhaqangalayo barnaamijka: Okt 01, 2021
Bixiye
P57-21 2022 Renewal Changes Summary for Primary Care Clinic Providers
Taariikhda uu dhaqangalayo barnaamijka: Okt 01, 2021
Bixiye
QP78-21 Commercial Pharmacy Benefit Update – New Drug-Related Quantity Limit (QL) Criteria: Stromectol® (ivermectin)
Taariikhda uu dhaqangalayo barnaamijka: Okt 13, 2021
Bixiye
QP79-21 New Availity Appeal Portal Available to Create, Submit and Inquire on Post Service Claim Appeals
Taariikhda uu dhaqangalayo barnaamijka: Okt 13, 2021
Bixiye
Anti-Influenza Agents - Commercial
Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: Nov 01, 2024